Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside
Modify Date: 2024-01-29 19:47:41
Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside structure
|
Common Name | Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoriboside | ||
|---|---|---|---|---|
| CAS Number | 132723-01-4 | Molecular Weight | 462.43 | |
| Density | 1.5±0.1 g/cm3 | Boiling Point | 643.9±65.0 °C at 760 mmHg | |
| Molecular Formula | C24H19FN4O5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 343.2±34.3 °C | |
Use of Purine-9-beta-D-(3',5'-di-O-benzoyl-2'-deoxy-2'-fluoro)arabinoribosidePurine-9-b-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 9-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine |
|---|---|
| Synonym | More Synonyms |
| Description | Purine-9-b-D-(3’,5’-di-O-benzoyl-2’-deoxy-2’-fluoro)arabinoriboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 643.9±65.0 °C at 760 mmHg |
| Molecular Formula | C24H19FN4O5 |
| Molecular Weight | 462.43 |
| Flash Point | 343.2±34.3 °C |
| Exact Mass | 462.133942 |
| LogP | 4.30 |
| Vapour Pressure | 0.0±1.9 mmHg at 25°C |
| Index of Refraction | 1.674 |
| 9-(3,5-Di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)-9H-purine |
| MFCD25542491 |
| 9H-Purine, 9-(3,5-di-O-benzoyl-2-deoxy-2-fluoro-β-D-arabinofuranosyl)- |